IDEAS home Printed from https://ideas.repec.org/h/eme/rlwezz/s0193-589520180000028001.html
   My bibliography  Save this book chapter

“To Know Where You’re Going, Look at Where You’ve Been”

In: Healthcare Antitrust, Settlements, and the Federal Trade Commission

Author

Listed:
  • Deborah L. Feinstein

Abstract

The Federal Trade Commission (FTC) has initiated policies and legal challenges that have shaped the evolution of competition in healthcare. This chapter discusses not only discusses the current matters in healthcare competition, but it also gives a history of past issues faced by the FTC and the approaches used to resolve them. These FTC actions range from challenges to hospital mergers to preventing “reverse payments” from patent holders to generic entrants in pharmaceuticals. Ultimately the healthcare industry faces many unique regulatory and competitive aspects that, while challenging, do not require special rules.

Suggested Citation

  • Deborah L. Feinstein, 2018. "“To Know Where You’re Going, Look at Where You’ve Been”," Research in Law and Economics, in: Healthcare Antitrust, Settlements, and the Federal Trade Commission, volume 28, pages 1-24, Emerald Group Publishing Limited.
  • Handle: RePEc:eme:rlwezz:s0193-589520180000028001
    DOI: 10.1108/S0193-589520180000028001
    as

    Download full text from publisher

    File URL: https://www.emerald.com/insight/content/doi/10.1108/S0193-589520180000028001/full/html?utm_source=repec&utm_medium=feed&utm_campaign=repec
    Download Restriction: no

    File URL: https://www.emerald.com/insight/content/doi/10.1108/S0193-589520180000028001/full/epub?utm_source=repec&utm_medium=feed&utm_campaign=repec&title=10.1108/S0193-589520180000028001
    Download Restriction: no

    File URL: https://www.emerald.com/insight/content/doi/10.1108/S0193-589520180000028001/full/pdf?utm_source=repec&utm_medium=feed&utm_campaign=repec
    Download Restriction: no

    File URL: https://libkey.io/10.1108/S0193-589520180000028001?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    Federal Trade Commission; healthcare antitrust; mergers; competition in pharmaceuticals; antitrust litigation; Noerr-Pennington doctrine; L4; K21;
    All these keywords.

    JEL classification:

    • L4 - Industrial Organization - - Antitrust Issues and Policies
    • K21 - Law and Economics - - Regulation and Business Law - - - Antitrust Law

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eme:rlwezz:s0193-589520180000028001. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Emerald Support (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.